NKP-1339 dronic acid Suplatast tosilate also significantly inhibits

Suplatast tosilate also significantly inhibits the secretion of CCL17

It is a selective cyclooxygenase-2 inhibitor

VPC-14337 also efficiently down-regulates the expression of other stemness genes including ALDH1

C6H8O7/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23

3)19(27)29-13-28-18(26)15-21(4

NKP-1339 dronic acid Suplatast tosilate also significantly inhibitsNKP 1339, aslo known as IT 139 and KP 1339, is a ruthenium based anticancer drug in clinical development against solid cancer with limited side effects. NKP 1339 shows promising results in solid tumors, such as non small cell lung cancer, colorectal carcinoma, and most distinctively in gastrointestinal neuroendocrine tumors. Product information CAS Number: 197723 00 5 Molecular Weight: 502. 14 Formula: C14H12Cl4N4NaRu Synonym: IT 139 KP 1339 Chemical